Since the age of nine or ten, Katie Burns has had debilitating pain from endometriosis, a condition where tissue resembling the uterine lining grows outside the uterus. For years, Katie was in the dark about what was causing her pain. Even after a diagnosis at age 20 it was hard to find relief, or even answers about her condition. Her search for better care is part of what led her to a career studying the disease, which affects tens of millions of people worldwide. And in 2012, she discovered something new about its origins. Today, we talk to Katie and science reporter Meredith Wadman about that discovery, which points to a surprising culprit of endometriosis — the immune system.Read Meredith’s full piece in Science Magazine HERE. Interested in more health science ? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
Wissenschaft & Technik
Short Wave Folgen
New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong and Regina Barber for science on a different wavelength.If you're hooked, try Short Wave Plus. Your subscription supports the show and unlocks a sponsor-free feed. Learn more at plus.npr.org/shortwave
Folgen von Short Wave
1393 Folgen
-
Folge vom 26.09.2025A Surprising Cause Of Endometriosis Could Lead To Cure
-
Folge vom 24.09.2025Tylenol and Autism: What’s True and What Isn’tOn Monday, the Trump administration linked the use of Tylenol with rising autism rates, but science doesn’t support that claim. Guest host Sydney Lupkin talks to autism researcher Helen Tager-Flusberg about how autism is studied, the findings from decades of research, and what people–especially those who are pregnant–should do when they experience pain or fever. Plus, we dig into guidance behind using leucovorin to treat autism.Interested in more science behind the headlines? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 23.09.2025A Surprising Culprit of Food AllergiesFood allergies have risen in the United States over the last few decades. Research suggests that 40 years ago the prevalence of food allergies was less than 1%. But today that number is closer to 6%. But this trend is not present in all countries — and what people are allergic to varies globally. Today, we dive into the complex world of food allergies with Dr. Waheeda Samady. She's the director of clinical research at Northwestern University's Center for Food Allergy and Asthma Research.Have a food science question? Email us at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 22.09.2025Should You Try Red-Light Therapy?The anti-aging product market was worth roughly 53 BILLION dollars in 2024. One of the latest big trends: red light therapy. Social media is rampant with claims about all sorts of purported health benefits to using directed red light regularly … but does the research really live up to all the hype?For answers, we turn to cosmetic chemist and science communicator Michelle Wong. Together, she and host Regina G. Barber sift through the thin (albeit growing) research on red light therapy to find out which claims are clearly backed by the literature – and which still need a bit more experimental data. Interested in more science behind skincare products? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy